Professor Ken Smith
MA BMedSc MBBS PhD FRACP FRCPA FRCP FHEA FMedSci
Ken Smith is Professor of Medicine and Head of the Department of Medicine at the University of Cambridge. His laboratory studies basic immunological mechanisms and how defects in regulatory control of the immune system can lead to autoimmunity and alter defence against infection. The laboratory has extensive experience in immune phenotyping and application of “omics” technologies to both healthy controls and patients with immune-mediated disease. The skills and infrastructure established has also put us in an excellent position to explore the immue phenotype of COVID-19.
Ken is an active Clinician in nephrology, transplantation and general medicine at Addenbrooke’s Hospital. He also leads strategy in immunity and infection in the Cambridge School of Clinical Medicine, having established the Immunology Strategic Research Network and the Cambridge FOCIS Centre of Excellence, been an NIHR BioResource Theme Lead for Immunity, Infection and Inflammation since 2007 and set up the NIHR BRC Cell Phenotyping Hub. More recently he raised funds to establish, and now direct, the Cambridge Institute for Therapeutic Immunity and Infectious Disease (CITIID), which opened in 2019, to drive strategic expansion in infectious (AMR, pandemic disease and vaccinology) and inflammatory disease, in a global context. It recently opened the largest academic CL3 facility in the UK. CITIID has been the focus for COVID-19 research on the Cambridge Biomedical Campus, staying open throughout the pandemic with all 150 scientists focused on SARS-CoV-2 and COVID-19 research.
Executive Assistant – Laura Messer